Report overview
This report contains market size and forecasts of Type 2 Diabetes Therapeutics in Global, including the following market information:
Global Type 2 Diabetes Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Type 2 Diabetes Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
DPP-4 Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Type 2 Diabetes Therapeutics include AstraZeneca, Novartis, Novo Nordisk, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Merck and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Type 2 Diabetes Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Type 2 Diabetes Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Type 2 Diabetes Therapeutics Market Segment Percentages, by Type, 2021 (%)
DPP-4 Inhibitors
Biguanides
Insulins
SGLT-2 Inhibitors
?-Glucosidase Inhibitors
Other
Global Type 2 Diabetes Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Type 2 Diabetes Therapeutics Market Segment Percentages, by Application, 2021 (%)
Children
Middle-Aged Person
Aged
Global Type 2 Diabetes Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Type 2 Diabetes Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Type 2 Diabetes Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Type 2 Diabetes Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Novartis
Novo Nordisk
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Merck
Sanofi
